|
2023 Conference Publication Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC)Hayne, Dickon, Stockler, Martin R., Martin, Andrew James, McCombie, Steve P., Zebic, Danka Sinikovic, Bastick, Patricia A., Beardsley, Emma Kate, Frydenberg, Mark, Green, William, Grummet, Jeremy, Hawks, Cynthia, Ischia, Joseph, Mitterdorfer, Andrew, Patel, Manish, Roberts, Matthew, Sengupta, Shomik, Srivastav, Ratnesh Kumar, Redfern, Andrew David and Davis, Ian D. (2023). Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins. doi: 10.1200/JCO.2023.41.16_suppl.TPS4617 |
|
2023 Conference Publication PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James Patrick, Moon, Daniel, Fahey, Michael T., Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Yeung, Theresa, De Abreu Lourenço, Richard, Dhillon, Haryana M., Hofman, Michael S and Emmett, Louise (2023). PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. 2023 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 16-18 February 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.6_suppl.tps397 |
|
2023 Conference Publication PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James Patrick, Moon, Daniel, Fahey, Michael T., Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Yeung, Theresa, Lourenco, Richard De Abreu, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. Genitourinary Cancers Symposium, Electr Network, 16-18 February 2023. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2023.41.6_suppl.TPS397 |
|
2023 Conference Publication Baseline PSMA PET-CT is prognostic for treatment failure in men with intermediate-to-high risk prostate cancer: 54 months follow-up of the proPSMA randomised trialKasivisvanathan, V., Murphy, D.G., Link, E., Lawrentschuk, N., O’Brien, J., Buteau, J.P., Roberts, M., Francis, R.J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J., Frydenberg, M., Shakher, R., Wong, L-M., Taubman, K., Lee, S.T., Hsiao, E., Nottage, M., Kirkwood, I., Iravani, A., Williams, S. and Hofman, M.S. (2023). Baseline PSMA PET-CT is prognostic for treatment failure in men with intermediate-to-high risk prostate cancer: 54 months follow-up of the proPSMA randomised trial. EAU23 - 38th Annual EAU Congress, Milan, Italy, 10-13 March 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(23)01275-7 |
|
2022 Conference Publication Genetic testing in prostate cancer: a scoping literature reviewEdmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2022 Conference Publication Incidence and risk factors for urinary tract infections following trial of voidKwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John and Roberts, Matthew (2022). Incidence and risk factors for urinary tract infections following trial of void. HOBOKEN: WILEY. |
|
2022 Conference Publication Management of recurrent urinary tract infections: Comparison of nine guidelines from major urological and non-urological organisationsKwok, Michael, Mcgeorge, Stephen, Mayer-Coverdale, Johanna, Graves, Bianca, Paterson, David L., Harris, Patrick N. A., Esler, Rachel, Dowling, Caroline, Britton, Sumudu and Roberts, Matthew (2022). Management of recurrent urinary tract infections: Comparison of nine guidelines from major urological and non-urological organisations. HOBOKEN: WILEY. |
|
2022 Conference Publication Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC)Pathmanathan, Shivanshan, Tariq, Arsalan, Gan, Chun Loo, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Philip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C. and Roberts, Matthew (2022). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, 3-7 June 2022. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2022.40.16_suppl.4540 |
|
2020 Conference Publication Safer, better bang for buck: improved efficiency and safety of prostate biopsy for prostate cancer diagnosis using MRI and transperineal biopsy methodRoberts, Matthew, Tariq, Arsalan, Morton, Andrew, Donato, Peter, Macdonald, Alistair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick, Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert, Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Safer, better bang for buck: improved efficiency and safety of prostate biopsy for prostate cancer diagnosis using MRI and transperineal biopsy method. HOBOKEN: WILEY. |
|
2020 Conference Publication Comparing hybrid PSMA PET MRI and prostate biopsy histopathology in presumed localised prostate cancerMehawed, Georges, Tariq, Arsalan, Saadat, Paria, Joshi, Andre, Roberts, Matthew, Perera, Marlon, Rhee, Handoo, Gustafson, Sonja, Miles, Kenneth and Vela, Ian (2020). Comparing hybrid PSMA PET MRI and prostate biopsy histopathology in presumed localised prostate cancer. 18th Urological Association of Asia (UAA) Congress, Seoul, Korea, 15–17 October 2020. Richmond, VIC Australia: John Wiley & Sons. |
|
2020 Conference Publication Correlation between hybrid PSMA PET MRI and histopathology at radical prostatectomyMehawed, G., Tariq, A., Saadat, P., Joshi, A., Roberts, M., Perera, M., Rhee, H., Yeates, A., Mckenzie, I., Munns, J., Chung, E., Heathcote, P., Preston, J., Lawson, M., Wood, S., Gustafson, S., Miles, K. and Vela, I. (2020). Correlation between hybrid PSMA PET MRI and histopathology at radical prostatectomy. EAU20 Virtual Congress and Theme Week, Online, 17-26 July 2020. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2666-1683(20)32890-1 |
|
2020 Conference Publication Improved Lower Urinary Tract Symptoms (LUTS) after robotic assisted radical prostatectomy (RARP): implications for prostate cancer (CaP) survivorship and treatment selectionAhn, T., Roberts, M. J., Strahan, A., Malone, G., Paterdis, J., Wood, G. and Heathcote, P. (2020). Improved Lower Urinary Tract Symptoms (LUTS) after robotic assisted radical prostatectomy (RARP): implications for prostate cancer (CaP) survivorship and treatment selection. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2020 Conference Publication Ga-68-PSMA PET/CT outperforms mpMRI at intra-prostatic tumour characterisation following biopsy: should Ga-68-PSMA PET/CT be included earlier in the prostate cancer pathway?Donato, P., Raveenthiran, S., Roberts, M., Yaxley, W., Morton, A., Ranasinghe, S., Teloken, P., Kyle, S., Pokorny, M., Coughlin, G., Esler, R., Dunglison, N., Gardiner, R. A., Kua, B., Gianduzzo, T. and Yaxley, J. (2020). Ga-68-PSMA PET/CT outperforms mpMRI at intra-prostatic tumour characterisation following biopsy: should Ga-68-PSMA PET/CT be included earlier in the prostate cancer pathway?. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2020 Conference Publication Analysis of national trends in the management of benign prostatic hyperplasia in Australia: updated population-based dataChung, E., Teloken, P., Yaxley, J., Morton, A., Williams, M., Donato, P., Perera, M., Ranasinghe, S., Bolton, D. and Roberts, M. (2020). Analysis of national trends in the management of benign prostatic hyperplasia in Australia: updated population-based data. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2020 Conference Publication Optimal detection of bone metastasis in primary staging of prostate cancer: direct comparison of 68-Gallium Prostate Specific Membrane Antigen (PSMA) with bone scan in 532 patientsShanmugasundaram, R., Roberts, M., Wong, V., Arianayagam, M., Canagasingham, B., Ferguson, R., Goolam, A., Khadra, M., Ko, R., Varol, C., Winter, M., Loh, H., Le, K., Mansberg, R., Nguyen, D. N., Bui, C., Loh, H. and Le, K. (2020). Optimal detection of bone metastasis in primary staging of prostate cancer: direct comparison of 68-Gallium Prostate Specific Membrane Antigen (PSMA) with bone scan in 532 patients. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2020 Conference Publication Morbidity and cost implications of shifting from routine transrectal ultrasound-guided prostate biopsy to mpMRI triage with selective transperineal prostate biopsy: A 12-year retrospective analysis from a tertiary referral centreRoberts, M., Macdonald, A., Teloken, P., Ranasinghe, S., Bennett, H., Gardiner, R., Dunglison, N., Esler, R. and Yaxley, J. (2020). Morbidity and cost implications of shifting from routine transrectal ultrasound-guided prostate biopsy to mpMRI triage with selective transperineal prostate biopsy: A 12-year retrospective analysis from a tertiary referral centre. 73rd Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Sydney, NSW Australia, 7-10 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2019 Conference Publication Improved Lower Urinary Tract Symptoms (LUTS) After Robotic Assisted Laparoscopic Prostatectomy (RALP): Implications for Prostate Cancer (CAP) Survivorship, Treatment Selection and Patient CounsellingAhn, Thomas, Roberts, Matthew J., Strahan, Andrew, Malone, Greg, Paterdis, Jason, Wood, Glen and Heathcote, Peter (2019). Improved Lower Urinary Tract Symptoms (LUTS) After Robotic Assisted Laparoscopic Prostatectomy (RALP): Implications for Prostate Cancer (CAP) Survivorship, Treatment Selection and Patient Counselling. HOBOKEN: WILEY. |
|
2019 Conference Publication Changing trends in surgical management of renal tumours: an Australian retrospective study in the private sectorAli, S., Ahn, T., Papa, N., Perera, M., Wood, S. and Roberts, M. (2019). Changing trends in surgical management of renal tumours: an Australian retrospective study in the private sector. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY. |
|
2019 Conference Publication 68 Ga-PSMA PET in advanced prostate cancer updated diagnostic utility, sensitivity and specificity and distribution of PSMA-avid lesions systematic review and meta-analysisPerera, M., Papa, N., Williams, M., Roberts, M., Udovicic, C., Vela, I., Bolton, D., Lawrentschuk, N. and Murphy, D. (2019). 68 Ga-PSMA PET in advanced prostate cancer updated diagnostic utility, sensitivity and specificity and distribution of PSMA-avid lesions systematic review and meta-analysis. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY. |
|
2019 Conference Publication A systematic review of spontaneous renal haemorrhage in pregnancyAhn, T., Roberts, M., Navaratnam, A., Chung, E. and Wood, S. (2019). A systematic review of spontaneous renal haemorrhage in pregnancy. Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD, Australia, 13-16 April 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.14725 |
